These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 16121692)

  • 1. SPK-843 (Aparts/Kaken).
    Kasanah N; Hamann MT
    Curr Opin Investig Drugs; 2005 Aug; 6(8):845-53. PubMed ID: 16121692
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Icofungipen (PLIVA).
    Yeates C
    Curr Opin Investig Drugs; 2005 Aug; 6(8):838-44. PubMed ID: 16121691
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Introduction to antifungal drugs.
    Dismukes WE
    Clin Infect Dis; 2000 Apr; 30(4):653-7. PubMed ID: 10770726
    [No Abstract]   [Full Text] [Related]  

  • 4. [Antifungal resistance in opportunistic pathogenic fungi (I). Polyenes and fluorocytosine].
    Martínez-Suárez JV; Rodríguez-Tudela JL
    Enferm Infecc Microbiol Clin; 1996; 14(6):384-9. PubMed ID: 8756218
    [No Abstract]   [Full Text] [Related]  

  • 5. Is there a role for polyenes in treating invasive mycoses?
    Cornely OA; Vehreschild JJ; Ullmann AJ
    Curr Opin Infect Dis; 2006 Dec; 19(6):565-70. PubMed ID: 17075332
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current and future antifungal therapy: new targets for antifungal therapy.
    Andriole VT
    Int J Antimicrob Agents; 2000 Nov; 16(3):317-21. PubMed ID: 11091055
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Antifungals for systemic use].
    Ruiz-Camps I; Cuenca-Estrella M
    Enferm Infecc Microbiol Clin; 2009 Jun; 27(6):353-62. PubMed ID: 19482382
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical comparative studies of the effectiveness of polyfungin and nystatin Polfa in the treatment of infections of the skin and mucous membranes caused by yeast-like fungi].
    Bienias L; Ruszczak Z; Kurnatowska A; Kwaśniewska
    Przegl Dermatol; 1976; 63(5):673-8. PubMed ID: 794932
    [No Abstract]   [Full Text] [Related]  

  • 9. Current status and future of antifungal therapy for systemic mycoses.
    Nosanchuk JD
    Recent Pat Antiinfect Drug Discov; 2006 Jan; 1(1):75-84. PubMed ID: 18221136
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacodynamic implications for use of antifungal agents.
    Lewis RE
    Curr Opin Pharmacol; 2007 Oct; 7(5):491-7. PubMed ID: 17616480
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent approaches to antifungal therapy for invasive mycoses.
    Mathew BP; Nath M
    ChemMedChem; 2009 Mar; 4(3):310-23. PubMed ID: 19170067
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Concentration control: a key to phase I development of immunosuppressive agents.
    Kahan BD
    Transplant Proc; 1994 Dec; 26(6):3203-4. PubMed ID: 7998116
    [No Abstract]   [Full Text] [Related]  

  • 13. [Review article. Molecular basis of antimycotic therapy].
    Bastert J; Korting HC
    Mycoses; 1999; 42 Suppl 1():73-9. PubMed ID: 10592721
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antifungal drugs.
    Treat Guidel Med Lett; 2005 Feb; 3(30):7-14. PubMed ID: 15671963
    [No Abstract]   [Full Text] [Related]  

  • 15. Management of invasive fungal infections: a role for polyenes.
    Chandrasekar P
    J Antimicrob Chemother; 2011 Mar; 66(3):457-65. PubMed ID: 21172787
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Mycotic corneal ulcer treated with aureofuscin--experimental study and clinical experience with 248 cases].
    Fan DZ
    Zhonghua Yan Ke Za Zhi; 1985 Sep; 21(5):257-60. PubMed ID: 3937697
    [No Abstract]   [Full Text] [Related]  

  • 17. Globoroseomycin, a new antifungal antibiotic.
    Yukun L; Yingyuan Z; Zhiling Z; Meifang Z; Ziying D; Tiancai L; Jiezhi F; Jinji H
    Chin Med J (Engl); 1979 Jul; 92(7):443-50. PubMed ID: 114368
    [No Abstract]   [Full Text] [Related]  

  • 18. [Antifungal polyene macrolides. The relation of structure and biological activity].
    Shenin IuD
    Antibiot Khimioter; 1988 Aug; 33(8):622-30. PubMed ID: 3058066
    [No Abstract]   [Full Text] [Related]  

  • 19. Pharmacologic management of keratomycoses.
    Johns KJ; O'Day DM
    Surv Ophthalmol; 1988; 33(3):178-88. PubMed ID: 3068821
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overview of clinical studies and liposomal formulations of hamycin.
    Bhopale GM
    Hindustan Antibiot Bull; 2007 Feb-2008 Nov; 49-50(1-4):1-4. PubMed ID: 19957536
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.